01
Product positioning
A lead product story for neurovascular research.
Aildenafil is introduced through the current company source, with a clear distinction between product positioning and preclinical evidence.
Aildenafil / Product profile
Aildenafil phosphate, presented with precision.
A source-mapped product profile for Aildenafil phosphate tablets, separated from the evidence library.
01 / aildenafil
The product story is a marketing layer with evidence links, not an online pharmacy page.
Product profile
Aildenafil phosphate tablets
Aildenafil phosphate is the lead product story in the Lucius v1 scientific information platform, presented through source-mapped product information and preclinical research context.
Tablet / 片剂Aildenafil phosphate
30 mgStrength以艾迪拉菲计
50TabletsSource packaging
0.5 hExposure peakPK/PD context
1.24×Brain AUCvs plasma
02
Profile plate
Small facts, carefully placed.
Strength, package and research focus are shown as structured product facts. No price, stock, order or prescription path is present.
03
Continue
Move from profile to mechanism or evidence.
The next questions are how the mechanism is framed, what the mapped studies describe and where the source boundaries remain.
Continue exploring
Take the question one layer deeper.
01One canvas. Three connected directions.An interactive, source-aware mechanism narrative across vascular response, neurovascular recovery and neuroprotection.02The product story, seen through the study map.A product-focused index of the mapped preclinical and PK/PD evidence.03Safety information should be easy to find.Structured safety information from the current company source, with clear limits and a medical-information path.04A library built around provenance.Study summaries, source status and data modes for the current Aildenafil research baseline.